CannaLean Biotechs Ltd., founded in 2017 and headquartered in Israel,
CannaLean has established an active partnership with our main shareholders:
Mor Research Applications, the tech transfer company of CLALIT HEALTH SERVICES,
The largest HMO in Israel, with over 4.5M members, (14 full-scale hospitals specializing in all fields of medicine, as well as over 2000 community clinics with over 9000 employed physicians).
CannaLean is committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from Dyslipidemia.
CannaLean has completed various in vivo and pre-clinical studies showing a significant decrease in cholesterol/triglyceride blood levels, demonstrating the potential clinical effect of the novel patent-protected formulation.
Company Details
- Employees
- 3
- Founded
- 2017
- Address
- 14 Baruch Hirsh St, Bnei Brak,israel 5120206,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cannaleanbio.com/
- Keywords
- lipids, triglycerides, CBD, Cannabidiol, Cannabis, Pharma, FDA, Inovation, dyslipidemia, cholesterols.
- HQ
- Bnei Brak, Israel
Cannalean Biotechs Questions
Cannalean Biotechs's website is http://www.cannaleanbio.com/
Cannalean Biotechs's LinkedIn profile is https://cz.linkedin.com/company/cannalean-biotechs
Cannalean Biotechs has
3 employees.
View email and phone details for 3
employees at Cannalean Biotechs.
Cannalean Biotechs's industry is
Biotechnology Research
Cannalean Biotechs's top competitors are
Mndl Bio,
Dragonflow Systems Ltd,
Surgiai,
Yopi Tech,
Marpe Technologies,
Techmed-Ai,
Cannamore Biotechs,
Innovamed Sphere,
Fibioseq Medical Ltd,
Innoging Medical.
Cannalean Biotechs's categories are Biotechnology Research
Cannalean Biotechs's founding year is 2017
